JP Morgan's most recent trend suggests a bullish bias. One trading opportunity on JP Morgan is a Bull Put Spread using a strike $57.50 short put and a strike $52.50 long put offers a potential 15.47% return on risk over the next 32 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $57.50 by expiration. The full premium credit of $0.67 would be kept by the premium seller. The risk of $4.33 would be incurred if the stock dropped below the $52.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for JP Morgan is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for JP Morgan is bullish.
The RSI indicator is at 70.99 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for JP Morgan
Delamaide: CEO pay shows bank boards need change
Wed, 19 Feb 2014 00:13:22 GMT
What Arrests on Wall Street Mean for Investors
Wed, 19 Feb 2014 00:02:00 GMT
Does JPMorgan Chase Have the Potential for New Highs?
Tue, 18 Feb 2014 20:55:03 GMT
TABLE-Delinquency rates rise at major U.S. banks in January
Tue, 18 Feb 2014 20:23:28 GMT
Actavis to buy Forest for $25 billion; windfall for investor Icahn
Tue, 18 Feb 2014 20:21:06 GMT
Reuters – (Reuters) – Generic drugmaker Actavis Plc (ACT.N) said on Tuesday it would buy Forest Laboratories Inc (FRX) for about $25 billion in cash and stock, giving it a major focus on higher-margin, branded treatments for Alzheimer's, hypertension and other disorders. The deal also means a major payday for activist investor Carl Icahn, the second-largest shareholder at Forest Labs, who waged two proxy battles and threatened a third to change its leadership and strategy. Actavis said it would pay the equivalent of $89.48 per share, representing a premium of 25 percent to Forest's closing price on Friday. The offer comprises $26.04 in cash and 0.3306 Actavis share for every Forest share.
Related Posts
Also on Market Tamer…
Follow Us on Facebook